“BLOOD-BASED BIOMARKERS FOR PREDICTING POST-STROKE PROGNOSIS: A SCOPING REVIEW OF PENTRAXIN-3, NEUROPENTRAXIN-1, AND NEUROPENTRAXIN-2”, magna-neurologica, vol. 4, no. 2, pp. 175–186, Jul. 2026, doi: 10.20961/magnaneurologica.v4i2.3308.